SAN FRANCISCO, Dec. 3 – NuGen Technologies, a privately-held San Carlos, Calif., genetic analysis company, raised $10.8 million in Series B financing, the company announced Monday.

The investor group was led by Pequot Ventures, an investment arm of Pequot Capital Management, based in Westport, Conn. Additional investors included SoftBank LifeScience Ventures, Radius Venture Partners, MedCapital, Band of Angels Fund, and Tenex Medical Investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.